AFX-1251

N/A

Report date: 2025/07/22 15:51:41
NME

Base Information

Drug NameAFX-1251
Drug Alias NameAFX-1251AFX-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf modulators
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAfecta Pharmaceuticals IncUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesAfecta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A